Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non‐alcoholic fatty liver disease
Decompensation
DOI:
10.1111/apt.14342
Publication Date:
2017-09-28T16:03:59Z
AUTHORS (5)
ABSTRACT
Non-alcoholic fatty liver disease (NAFLD) is expected to become a leading aetiology of hepatocellular carcinoma (HCC)-related mortality in the United States. HCC treatments with curative intent (OLT, orthotopic transplantation; resection; RFA, radiofrequency ablation) can improve survival carefully selected patients.To compare after receipt treatment for NAFLD and non-NAFLD-HCC aetiologies (HCV, chronic hepatitis C; HBV, B; ALD, alcoholic disease) by was performed.A cohort 17 664 patients assembled using linked Surveillance, Epidemiology, End Results Medicare data from 1991 2011 confirmed diagnosis HCC.The mostly male, aged 70 (21-106) years, without cardiovascular disease, had cirrhosis decompensation, metastatic or large tumour size (>5 cm). The NAFLD-HCC group female older more HCC, less decompensated than groups. 47% likely receive any as compared non-NAFLD (OR 0.53, P < .001). worse median OLT (3.2, 0-12.9 = .01) but improved resection (2.4, 0-12.0 .001) non-NAFLD-HCC. No significant differences existed RFA aetiology. not an independent predictor OLT, RFA.Patients favourable resection, particularly absence cirrhosis, aetiologies.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (30)
CITATIONS (46)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....